Review of the cardiovascular diseases

Тип статьи:
Авторская



Review of the cardiovascular diseases

Review of the cardiovascular diseases


Sa isang mundo kung saan ang stress at pagmamadali ay nagiging bahagi ng araw-araw na buhay, mas nagiging mahalaga ang pagpapahalaga sa kalusugan ng puso. Ang mataas na presyon ng dugo o hypertension ay nagiging mas karaniwan sa mga tao sa lahat ng edad. Gayunpaman, may iba't ibang paraan at pamamaraan para kontrolin ang presyon at mapabuti ang paggana ng cardiovascular system. Isa sa mga epektibong paraan ay ang Cardio Balance Capsules, isang natatanging solusyon para mapanatili ang kalusugan ng puso at maibalik sa normal ang presyon ng dugo. Tara, alamin natin nang sama-sama kung ano ang mga kapsul na ito at paano ito tamang gamitin.

>>> ПЕРЕЙТИ НА ОФИЦИАЛЬНЫЙ САЙТ <<<









































Review of cardiovascular disease: methods and clinical relevance Introduction Cardiovascular diseases (CVD) are one of the leading causes of death worldwide, and require an early and precise diagnosis. A systematic Review of the CVD is a combination of anamnestic, clinical and instrumental examination methods, which allow for an adequate assessment of cardiovascular risk. Methods of diagnosis History and physical examination The medical history forms the basis of any cardiovascular diagnostics. Important aspects are: family history of heart attacks or strokes; Style factors (Smoking, alcohol consumption, physical inactivity) life; The presence of risk factors such as hypertension, Diabetes mellitus, and dyslipidemia; subjective complaints (chest pain, shortness of breath, palpitations, Edema). On physical examination, in particular, the blood will be evaluated pressure, heart rate, heart sounds, and signs of heart failure (e.g., cervical venous congestion, Edema). Laboratory analyses For the evaluation of CVD, the following laboratory parameters will be investigated: Lipid spectrum (total cholesterol, LDL‑cholesterol, HDL‑cholesterol, triglycerides); Blood glucose and HbA1c for diagnosis of Diabetes mellitus; Renal function (creatinine, eGFR); High-sensitive Troponin for the detection of myocardial ischemia or Infarction; Natriuretic peptides (BNP or NT‑proBNP) in the case of suspected heart failure. EleInstrumente Studies EleElektrokardiogramm (ECG): Enables the detection of arrhythmias, Ischemia, and infarction follow. Echocardiography (Echo): Represents the structure and function of the heart, including ventricular function, Valvular and pericardial diseases. Exercise ECG / Stress Echo: Serves for the diagnosis of coronary heart disease with unclear chest pain. Coronary computed tomography (CT): Visualize atherosclerosis of the coronary arteries, and Calcifications. Long‑term ECG and long‑term blood pressure measurement is Important for the detection of arrhythmic events and blood pressure over 24 hours. Invasive Procedures In case of uncertain diagnosis or a high suspicion of density, a heart catheterization may be performed. This allows you to: Measurement of the pressure in the chambers of the heart; Representation of the coronary arteries (coronary angiography); Assessment of ventricular function (Ventriculography). Conclusion The Review of cardiovascular disease requires a gradual approach, ranging from the history to the more invasive procedures. Early identification of risk factors and diseases allows for the effective prevention and therapy, which can improve the quality of life and life expectancy of the patients significantly. Advances in imaging and laboratory diagnostics allow for increasingly precise and non‑invasive diagnostic methods, which are possible in the future for a more customized treatment.

Nililinis ang mga ugat na kailangang alagaan mula sa deposito at pinananatili ang kinakailangang lakas ng tibok ng puso! Review of the cardiovascular diseases. Isang malawak na pagpipilian ng mga gamot mismo pati na rin ng mga pamamaraan para sa pagbawas ng gamot mula sa mataas na presyon ang nagbibigay-daan sa iyo na pumili ng pinaka-komportableng programa ng paggamot – ang abot-kaya sa gastos, na may minimal na pagpapakita ng mga side effect, at isinasaalang-alang ang ibang kasamang sakit. Kapag matagal ang pag-inom ng tabletas at binabago ng doktor ang gamot, ito ay dahil ang ilang gamot ay may katangian na magdulot ng pagkagumon, na nagreresulta sa kaunting pagbaba ng bisa nito. Bukod dito, hindi lahat ng grupo ng gamot ay angkop para sa mga pasyente sa iba't ibang edad, at may mga limitasyon din sa pagiging compatible nito sa ibang uri ng gamot.

Prevention of cardiovascular disease lecture

Preventive Measures For Cardiovascular Diseases

Cardiovascular disease in the Genesis

Sanatorium profile of cardiovascular diseases

http://jnnycc.org/userfiles/hypertension-obesity-5409.xml

http://hcnapa.com/userfiles/7323-the-fight-against-cardiovascular-diseases-of-the-national-project.xml

I have two stents inserted in my heart and have been dealing with nerve-wracking irregular heartbeat my whole life. I decided to give Cardio Balance a try, and I thank God for it! Just after using it for a couple of weeks, my irregular heart beating became normal. I feel more ALIVE, young, and energetic. Una sa lahat, ang mga Beta-blocker ay karaniwang ibinibigay sa mga pasyente na may heart failure, aortic aneurysm, pagkatapos ng myocardial infarction, at sa mga kababaihan na nasa edad ng pagbubuntis, lalo na sa mga kababaihang nagpaplano ng pagbubuntis. Madalas matanggap ng katawan ang Beta-blocker, pero maaari rin itong magdulot ng pantal sa balat at bradycardia – sobrang bagal ng tibok ng puso.


Google
Google

Coursework: prevention of cardiovascular diseases Introduction Cardiovascular diseases (CVD) are one of the leading causes of death worldwide and associated with significant socio-economic costs. According to the world health organization (WHO), you are in for nearly 17.9 million deaths annually responsible — that's the equivalent of around 32% of all deaths globally. The present work deals with the preventive measures to reduce the risk for cardiovascular diseases, investigated both individual and social strategies. Risk factors The main risk factors for CVD in modifiable and non-modifiable sub-parts: Non-modifiable factors: Genetic Predisposition; Age (the risk increases after the age of 40. Age significantly); Gender (men are at the age of 65. The age of affected to a greater extent). Modifiable Factors: Arterial Hypertension; Hyperlipidemia; Diabetes mellitus type 2; Overweight and obesity; Tobacco consumption; Lack of physical activity; Unbalanced diet (high in salt, sugar and fat content); Chronic Stress. Preventive Measures Effective prevention requires a multi-modal approach, based on different levels: Primary prevention (prevention of disease): Regular physical activity (150 minutes of moderate activity per week); Balanced diet according to the principle of the MEDITERRANEAN DIET (rich in fruits, vegetables, nuts, fish, olive oil); Reduction of salt consumption (<5 g per day); Waiver of tobacco Smoking and excessive alcohol consumption; Weight control (goal: BMI between 18.5 and 24.9 kg/m 2 ); Stress management techniques (e.g., Meditation, Yoga). Secondary prevention (screening and treatment): Regular Measurement Of Blood Pressure (Target Value: <140/90 mmHg); Lipid spectrum control (LDL‑cholesterol <3.0 mmol/l); Blood Sugar Measurement (Hba1c <7% in diabetics); Drug therapy in high-risk (e.g., statins, antihypertensives). Tertiary prevention (minimization of secondary damage after an illness): Cardiac rehabilitation programs; Style change life after a heart attack or stroke; Long-term medication (e.g., ACE, beta-blockers). Social Prevention Strategies In addition to individual measures, company policies have a crucial role: Implementation of health promotion programs in schools and businesses; Control of food products with high sugar, salt and fat content; The promotion of Cycling and pedestrian zones to increase physical activity; Public awareness campaigns to heart health; Improving access to preventive medical examinations. Conclusion The prevention of cardiovascular diseases requires a combination of individual behavior and the social environment. Through the systematic reduction of modifiable risk factors, the disease risk can be significantly reduced, and the quality of life and expectancy of the population. Sustainable prevention policy must therefore be implemented at all levels — from the individual life — style change to the legislative regulation. Would you like me to make a certain section in more detail, or other aspects (e.g., study documents, statistics, translation AIDS) complementary?

Нет комментариев. Ваш будет первым!
Посещая этот сайт, вы соглашаетесь с тем, что мы используем файлы cookie.